Targeting Achilles’ Heel: Copper-Based Nanoantibiotics Synergistically Disrupt the TCA Cycle to Induce Bacterial Metabolic Cell Death
ACS Applied Materials & Interfaces · 2026
DOI: 10.1021/acsami.6c15149 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2026. Verfasst von Shujing Deng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi710061, China. Hauptthemen laut MEDLINE: Copper, Anti-Bacterial Agents, Citric Acid Cycle, Metal Nanoparticles. Die Arbeit nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research and Development Projects of Shaanxi Province.
Abstract (Originalsprache)
Central carbon metabolism is essential for bacterial survival, making it a promising target for antimicrobial strategies. Bacterial cuproptosis-like and ferroptosis-like deaths are tightly linked to central carbon metabolism, yet their complete mechanistic cascades remain poorly understood. In addition, both death pathways are constrained by intracellular glutathione (GSH). Herein, we constructed chitosan-copper nanoclusters (CS-CuCs) as nanoantibiotics that selectively accumulate within bacteria to synergistically disrupt the tricarboxylic acid (TCA) cycle. CS-CuCs induces copper overload, impairs lipoylated and iron-sulfur (Fe-S) proteins, triggering cuproptosis-like death. Their peroxidase-like activity further generates reactive oxygen species, thereby exacerbating TCA cycle disruption. The subsequent dysfunction in central carbon metabolism reduces the supply of biosynthetic precursors of GSH, thereby compromising antioxidant defenses and provoking ferroptosis-like death. Metabolic collapse ultimately leads to cascading metabolic cell death in bacteria. Notably, CS-CuCs effectively eradicate biofilm-embedded and multidrug-resistant bacteria and exhibit excellent therapeutic efficacy in a mouse peritonitis-sepsis infection model. This study establishes a central carbon metabolism-targeted metabolic disruption strategy, providing a novel paradigm for triggering bacterial metabolic cell death.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi710061, China.
- School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi710061, China.
ORCID-Profile: Jianfeng Xing, Ying Zhang
Förderung
- National Natural Science Foundation of China
- Key Research and Development Projects of Shaanxi Province
Zitieren
APA
Deng, S., Chen, C., Tan, Q., Wang, D., Feng, H., Liu, S., Xing, J., & Zhang, Y. (2026). Targeting Achilles’ Heel: Copper-Based Nanoantibiotics Synergistically Disrupt the TCA Cycle to Induce Bacterial Metabolic Cell Death. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c15149
Vancouver
Deng S, Chen C, Tan Q, Wang D, Feng H, Liu S, et al. Targeting Achilles’ Heel: Copper-Based Nanoantibiotics Synergistically Disrupt the TCA Cycle to Induce Bacterial Metabolic Cell Death. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c15149
BibTeX
@article{Deng2026,
author = {Deng, Shujing and Chen, Chuanxin and Tan, Qichao and Wang, Danyang and Feng, Heng and Liu, Shiyu and Xing, Jianfeng and Zhang, Ying},
title = {Targeting Achilles’ Heel: Copper-Based Nanoantibiotics Synergistically Disrupt the TCA Cycle to Induce Bacterial Metabolic Cell Death},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
doi = {10.1021/acsami.6c15149}
}
EUVIMED